CREBBP and cervical carcinoma: EP300, which was previously identified to be recurrently mutated in cervical cancer [11], has a high sequence similarity to CREBBP. Both were determined to harbor recurrent mutations in the CBP/p300-type HAT domain, which functions as a histone acetyl-transferation (Fig. 3).